Showing results (231-240 of 293) with videos related to
Sort By:
Pageof 30
Bioorganic & Medicinal Chemistry Letters|December 26, 2008
Potent and selective adenosine A2A receptor antagonists: 1,2,4-Triazolo[1,5-c]pyrimidinesBernard R Neustadt, Hong Liu, Jinsong Hao, et al.Bioorganic & Medicinal Chemistry Letters|April 1, 2009
Identification of 3-substituted N-benzhydryl-nortropane analogs as nociceptin receptor ligands for the management of cough and anxietyShu-Wei Yang, Ginny Ho, Deen Tulshian, et al.Molecular Neurobiology|May 13, 2021
Decrease in Skin Prion-Seeding Activity of Prion-Infected Mice Treated with a Compound Against Human and Animal Prions: a First Possible Biomarker for Prion TherapeuticsMingxuan Ding, Kenta Teruya, Weiguanliu Zhang, et al.Pathogens (Basel, Switzerland)|December 2, 2014
Evaluation of the zoonotic potential of transmissible mink encephalopathyEmmanuel E Comoy, Jacqueline Mikol, Marie-Madeleine Ruchoux, et al.Nature Communications|July 8, 2025
Active light-controlled frontal ring-opening metathesis polymerizationD R Darby, A J Greenlee, R H Bean, et al.Bioorganic & Medicinal Chemistry Letters|June 19, 2008
Design, synthesis, and evaluation of fused heterocyclic analogs of SCH 58261 as adenosine A2A receptor antagonistsUnmesh Shah, Claire M Lankin, Craig D Boyle, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2011
Dual protective mechanisms of matrix metalloproteinases 2 and 9 in immune defense against Streptococcus pneumoniaeJeong-Soo Hong, Kendra J Greenlee, Ramanan Pitchumani, et al.Bioorganic & Medicinal Chemistry Letters|January 24, 2012
Fused tricyclic mGluR1 antagonists for the treatment of neuropathic painChad E Bennett, Duane A Burnett, William J Greenlee, et al.Journal of Medicinal Chemistry|September 16, 2005
Discovery of potent orally active thrombin receptor (protease activated receptor 1) antagonists as novel antithrombotic agentsSamuel Chackalamannil, Yan Xia, William J Greenlee, et al.Journal of Medicinal Chemistry|July 22, 2005
Biaryl ureas as potent and orally efficacious melanin concentrating hormone receptor 1 antagonists for the treatment of obesityAnandan Palani, Sherry Shapiro, Mark D McBriar, et al.Pageof 30